Bravelle (urofollitropin) is an injectable medication that treats certain fertility problems in women. Bravelle (urofollitropin) helps make it easier for women to get pregnant, but it's no longer available in the United States.
| Common Brands | Bravelle |
|---|---|
| Drug Class | Gonadotropin |
| Controlled Substance Classification | Not a controlled medication |
| Generic Status | No lower-cost generic available |
| Availability | Discontinued |
Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. Tell your healthcare professional if you are taking any other prescription or nonprescription (over-the-counter [OTC]) medicine.
Prescription savings
Stop paying too much for your prescriptions. Compare prices, get pharmacy coupons, and save up to 80%.
Find expert answers to your health questions so you can make the best decisions for yourself and your family.Health conditions
Medications & treatment
Access & affordability
Medication discounts
Bravelle is a synthetic (man-made) form of the natural hormone called gonadotropin. This medication helps the eggs in your ovaries grow and develop. Your ovaries can then produce more eggs and prepare for ovulation (the release of an egg from your ovaries). This can help make it easier for you to get pregnant.
No, Bravelle is currently not available in the United States.
The manufacturer (Ferring Pharmaceuticals) recalled Bravelle in October 2015, because there was concern about how well the medication works. This means that Bravelle might not be as effective as it should've been, so it was removed from the market.
